Literature DB >> 2319294

Vascular response to irradiation in malignant gliomas.

D Schiffer1, A Chiò, M T Giordana, A Mauro, A Migheli, R Soffietti, M C Vigliani.   

Abstract

The vascular response to irradiation was studied in peritumoral cortex and tumor areas in 9 autopsied cases of glioblastoma multiforme and in 10 biopsies of reoperated cases. The study was carried out by histological, immunohistochemical and electron microscope procedures. Hyaline thickening of the vessel walls with deformation and impoverishment of endothelial nuclei are the most striking features. Formation of large PAS-positive areas from the confluence of thickened vessel walls and development of a fibroblastic proliferation follow. Fibroblastic areas may entrap tumor glial cells. In PAS-positive areas a special population resembles myofibroblasts of tissue scars. Electron microscope reveals the production of collagen fibrils in and outside vessel walls. The presence of collagen III and IV is in line with the present interpretation of the mesodermic component.

Entities:  

Mesh:

Year:  1990        PMID: 2319294     DOI: 10.1007/bf00182090

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  The vascular response to tumor infiltration in malignant gliomas. Morphometric and reconstruction study.

Authors:  D Schiffer; A Chiò; M T Giordana; A Mauro; A Migheli; M C Vigliani
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Quantitative techniques for study of the anatomy and function of small blood vessels in tumors.

Authors:  I F Tannock; G G Steel
Journal:  J Natl Cancer Inst       Date:  1969-05       Impact factor: 13.506

3.  Capillary injury preceding radiation-induced myocardial fibrosis.

Authors:  L F Fajardo; J R Stewart
Journal:  Radiology       Date:  1971-11       Impact factor: 11.105

4.  Radiation necrosis.

Authors:  J R Fike; G E Sheline; C E Cann; R L Davis
Journal:  Prog Exp Tumor Res       Date:  1984

5.  Antibodies to distinct types of collagens and procollagens and their application in immunohistology.

Authors:  R Timpl; G Wick; S Gay
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

6.  Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma.

Authors:  R D McComb; T R Jones; S V Pizzo; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1982-09       Impact factor: 3.685

7.  Late functional changes in the vasculature of the rat brain after local X-irradiation.

Authors:  H F Moustafa; J W Hopewell
Journal:  Br J Radiol       Date:  1980-01       Impact factor: 3.039

Review 8.  The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases.

Authors:  P C Burger; M S Mahley; L Dudka; F S Vogel
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

9.  Simultaneous synthesis of types I and III collagen by fibroblasts in culture.

Authors:  S Gay; G R Martin; P K Muller; R Timpl; K Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  Irradiation and BCNU effects in the stroma in a rat transplanted glioma model: analysis of cerebral tumor bed effect.

Authors:  A M Spence; J P Geraci; R R Cent
Journal:  Neuropathol Appl Neurobiol       Date:  1985 May-Jun       Impact factor: 8.090

View more
  2 in total

1.  Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy.

Authors:  A Boiardi; A Silvani; A Pozzi; M Farinotti; L Fariselli; G Broggi; A Salmaggi
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

Review 2.  The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Authors:  Daniel J Brat; Timothy Charles Ryken; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2014-04-15       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.